Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Aurora Cannabis (TSX: ACB) (OTC: ACBFF) has publicly disclosed that it will be listing on a major exchange in the United States in October, but, until today, the exchange was unknown. The company revealed in a public filing, the Form 40-F, that it has registered to list on the New York Stock Exchange:
Aurora Cannabis hasn’t yet revealed the timing or its trading symbol, though ACB is apparently available. The company will join Canopy Growth (TSX: WEED) (NYSE: CGC), while Cronos Group (TSX: CRON) (NASDAQ: CRON) and Tilray (NASDAQ: TLRY) trade on the NASDAQ. Aleafia (TSXV: ALEF) (OTC: ALEAF) has filed its Form 40-F and intends to trade on the NASDAQ, while it is likely that Aphria (TSX: APH) (OTC: APHQF) and CannTrust (TSX: TRST) (OTC: CNTTF) will list on a major U.S. exchange as well.
Until Cronos Group listed on the NASDAQ earlier this year, no companies growing, processing or selling cannabis had done so with the exception of GW Pharma (NASDAQ: GWPH).
The most reliable, fact-based information on Aurora Cannabis found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.